HCP SATISFACTION WITH BIOPHARMA’S DIGITAL OFFERINGS HAS PLATEAUED AND REMAINS BELOW 50%
In EU5, satisfaction among specialists saw a pandemic-related rise but has since levelled off. Over half of HCPs remain either neutral about – or, worse, dissatisfied with – biopharma’s digital efforts, with the proportion describing themselves as "very satisfied" showing almost no change for the past few years. This shows there is still much room for improvement.
Interested to know if the trend is similar for other regions?
THERE IS SIGNIFICANT INTEREST IN AI, BUT ITS EFFECTIVE IMPLEMENTATION REMAINS CHALLENGING
AI is a hot topic in many industries, and pharma is no exception. There is strong interest in incorporating AI into customer engagement efforts. But it’s still early days for most companies…
Before you turn your AI ambitions into reality, do you have the basics – like data quality and organisation – already in place?